AI assistant
GlaxoSmithKline PLC — Director's Dealing 2016
Feb 1, 2016
5262_dirs_2016-02-01_38aa0a12-1ee9-463b-a009-41c74f2809c8.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 6546N
GlaxoSmithKline PLC
01 February 2016
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons
In accordance with DTR 3.1.4R(1)(a) and (c) I give details of changes in the interests of the following Directors and Persons Discharging Managerial Responsibilities ('PDMR') who acquired Ordinary Shares ('Shares') in GlaxoSmithKline plc ('GSK') at a price of 1367.57 pence per Share, following the re-investment of the dividend paid to shareholders on 14 January 2016.
| Director/PDMR | Shares |
| Sir Andrew Witty | 28.610 |
| Mr S Dingemans | 937.309 |
| Mr S A Hussain | 30.863 |
| Mr D S Redfern | 813.543 |
| Dr M M Slaoui | 164.460 |
| Ms C Thomas | 998.661 |
| Mr P C Thomson | 341.837 |
| Dr P J T Vallance | 1,210.723 |
| Ms E Walmsley | 939.015 |
| Connected Person | Shares |
| Mrs K Thomson (Connected Person to Mr P C Thomson) | 110.075 |
GSK was informed of these allocations on 28 January 2016.
V A Whyte
Company Secretary
1 February 2016
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSXFLFBQLFBBBL